成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart 0 Sign in  

[ CAS No. 56741-94-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 56741-94-7
Chemical Structure| 56741-94-7
Structure of 56741-94-7 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 56741-94-7 ]

Related Doc. of [ 56741-94-7 ]

Alternatived Products of [ 56741-94-7 ]
Product Citations

Product Details of [ 56741-94-7 ]

CAS No. :56741-94-7 MDL No. :MFCD00466412
Formula : C10H9N3O Boiling Point : -
Linear Structure Formula :- InChI Key :KXYGHDWFGFZJPJ-UHFFFAOYSA-N
M.W : 187.20 Pubchem ID :135420365
Synonyms :

Calculated chemistry of [ 56741-94-7 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 14
Num. arom. heavy atoms : 12
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 2.0
Molar Refractivity : 54.7
TPSA : 71.77 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.2 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.08
Log Po/w (XLOGP3) : 0.34
Log Po/w (WLOGP) : 1.03
Log Po/w (MLOGP) : 0.99
Log Po/w (SILICOS-IT) : 1.88
Consensus Log Po/w : 1.06

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.78
Solubility : 3.08 mg/ml ; 0.0165 mol/l
Class : Very soluble
Log S (Ali) : -1.41
Solubility : 7.26 mg/ml ; 0.0388 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -3.72
Solubility : 0.0358 mg/ml ; 0.000191 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.88

Safety of [ 56741-94-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302+H312+H332-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 56741-94-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 56741-94-7 ]
  • Downstream synthetic route of [ 56741-94-7 ]

[ 56741-94-7 ] Synthesis Path-Upstream   1~10

  • 1
  • [ 94-02-0 ]
  • [ 56741-94-7 ]
YieldReaction ConditionsOperation in experiment
86%
Stage #1: for 1 h; Heating / reflux
Stage #2: at 45℃; Heating / reflux
Intermediate 1A : Preparation of 4-chloro-6-phenylpyrimidin-2-amine; A suspension of guanidine carbonate (3.60 g, 20 mmol) in ethanol (120 mL) and toluene (20 mL) was refluxed under nitrogen for 1 h, during which time about 50 mL of solvent was removed by distillation. After the mixture was cooled to 45 °C, ethyl 3-oxo-3- phenylpropanoate (7.68 g, 40 mmol) was added and the solution was heated at reflux overnight. The desired product precipitated as a white solid during the reaction. Water (50 mL) was added to the reaction and the mixture was refluxed for an additional 30 min. After cooling to rt, the mixture was neutralized with 1N HC1 and placed in the refrigerator for 6 h. The solid was filtered, washed with water followed by ether and dried at 60 °C under vacuum to give the product as white solid (6.45 g, 86percent). MS ES: 188 (M+H) +, calcd 188; RT = 0.91 min; TLC (CH2C12/2M NH3 in MeOH 95/5) Rf = 0.10. A mixture of the above product (6.0 g, 32 mmol) and POC13 (100 mL) was heated at reflux for 1 h. The majority of the POC13 was removed in vacuo and the residue was diluted with EtOAc and poured over an ice/saturated NaHC03 solution. The aqueous layer was extracted with EtOAc and the combined organic layers were washed with brine, dried (Na2SO4), and concentrated. The crude organic concentrate was re-crystallized from EtOAc/ether to give the product 1A as an off-white powder (2. 8 g, 43percent). MS ES: 206 (M+H) +, calcd 206; RT = 2.49 min; TLC (CH2C12/2M NH3 in MeOH 95/5) Rf = 0.72. (Reference 1: H. L. Skulnick, S. D. Weed, E. E. Edison, H. E. Renis, W. Wierenga, and D. A. Stringfellow, J ; Med. Cllem. 1985, 28,1854-1869).
Reference: [1] Patent: WO2005/35507, 2005, A2, . Location in patent: Page/Page column 52
  • 2
  • [ 593-85-1 ]
  • [ 94-02-0 ]
  • [ 56741-94-7 ]
YieldReaction ConditionsOperation in experiment
70% at 80℃; Inert atmosphere General procedure: To a suspension of guanidine carbonate (1.5-5 eq) in ethanol (2 mL/mmol) was added γ-aryl-β-ketoester (1.43-26.6 mmol), and the reaction mixture heated at 80 °C for 15-64 h. Followingreaction completion by TLC, the mixture was cooled to ambient temperature, filtered and thesolid triturated with water (5-20 mL) and acetone (5-20 mL) to give the title compound.
Reference: [1] Tetrahedron, 2015, vol. 71, # 39, p. 7339 - 7343
[2] Journal of the American Chemical Society, 1998, vol. 120, # 27, p. 6761 - 6769
[3] Justus Liebigs Annalen der Chemie, 1891, vol. 262, p. 365
[4] Journal fuer Praktische Chemie (Leipzig), 1893, vol. <2> 47, p. 203
  • 3
  • [ 614-27-7 ]
  • [ 113-00-8 ]
  • [ 56741-94-7 ]
YieldReaction ConditionsOperation in experiment
800 mg With sodium methylate In methanol at 65℃; Inert atmosphere A mixture of methyl 3-oxo-3-phenylpropanoate (2.0 g) , guanidine (2.02 g) and sodium methanolate (1.12 g) in methanol (50 mL) was stirred at 65°C overnight under a nitrogen atmosphere. The reaction mixture was evaporated under reduced pressure. The residue was purified by washed with methanol: ethyl acetate (1:10) as eluent to give the desired compound (800 mg) as a white solid. LC-MS m/z [M+H]+ = 188 (calc=188) (ES+)
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2014, vol. 24, # 5, p. 1315 - 1321
  • 4
  • [ 50-01-1 ]
  • [ 94-02-0 ]
  • [ 56741-94-7 ]
Reference: [1] RSC Advances, 2014, vol. 4, # 29, p. 15087 - 15090
  • 5
  • [ 124-46-9 ]
  • [ 94-02-0 ]
  • [ 56741-94-7 ]
Reference: [1] Patent: US2001/27196, 2001, A1,
  • 6
  • [ 56741-95-8 ]
  • [ 98-80-6 ]
  • [ 66376-75-8 ]
  • [ 56741-94-7 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2000, vol. 8, # 4, p. 739 - 750
  • 7
  • [ 593-84-0 ]
  • [ 94-02-0 ]
  • [ 56741-94-7 ]
Reference: [1] Journal of the American Chemical Society, 1914, vol. 36, p. 1205
  • 8
  • [ 94-02-0 ]
  • [ 113-00-8 ]
  • [ 56741-94-7 ]
Reference: [1] Journal of Medicinal Chemistry, 1980, vol. 23, # 3, p. 237 - 239
[2] Journal of Medicinal Chemistry, 1985, vol. 28, # 12, p. 1864 - 1869
  • 9
  • [ 93-58-3 ]
  • [ 56741-94-7 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2014, vol. 24, # 5, p. 1315 - 1321
  • 10
  • [ 56741-95-8 ]
  • [ 56741-94-7 ]
Reference: [1] Analytical Chemistry, 1980, vol. 52, # 12, p. 1931 - 1934
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Related Functional Groups of
[ 56741-94-7 ]

Aryls

Chemical Structure| 109229-22-3

[ 109229-22-3 ]

6-Benzyl-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-4(3H)-one

Similarity: 0.75

Chemical Structure| 62458-96-2

[ 62458-96-2 ]

7-Benzyl-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4(3H)-one

Similarity: 0.68

Chemical Structure| 62259-92-1

[ 62259-92-1 ]

7-Benzyl-2-methyl-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4(3H)-one

Similarity: 0.62

Chemical Structure| 1290541-46-6

[ 1290541-46-6 ]

(E)-3-Benzyl-2-(2-(pyridin-3-yl)vinyl)quinazolin-4(3H)-one

Similarity: 0.62

Chemical Structure| 56741-95-8

[ 56741-95-8 ]

2-Amino-5-bromo-4-hydroxy-6-phenylpyrimidine

Similarity: 0.60

Amides

Chemical Structure| 19181-54-5

[ 19181-54-5 ]

8-Methylquinazolin-4(3H)-one

Similarity: 0.79

Chemical Structure| 75844-40-5

[ 75844-40-5 ]

7-Methylquinazolin-4(3H)-one

Similarity: 0.76

Chemical Structure| 124703-78-2

[ 124703-78-2 ]

6-Ethylpyrimidin-4(3H)-one

Similarity: 0.75

Chemical Structure| 17329-31-6

[ 17329-31-6 ]

6-Aminoquinazolin-4(3H)-one

Similarity: 0.75

Chemical Structure| 109229-22-3

[ 109229-22-3 ]

6-Benzyl-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-4(3H)-one

Similarity: 0.75

Amines

Chemical Structure| 17329-31-6

[ 17329-31-6 ]

6-Aminoquinazolin-4(3H)-one

Similarity: 0.75

Chemical Structure| 130148-53-7

[ 130148-53-7 ]

2-Amino-6-bromoquinazolin-4-ol

Similarity: 0.72

Chemical Structure| 65996-58-9

[ 65996-58-9 ]

2-Amino-3H-pyrrolo[3,2-d]pyrimidin-4(5H)-one

Similarity: 0.68

Chemical Structure| 116568-17-3

[ 116568-17-3 ]

1H-Benzo[d]imidazole-6-carboxamide

Similarity: 0.63

Chemical Structure| 6531-74-4

[ 6531-74-4 ]

N-Carbamimidoylisonicotinamide

Similarity: 0.62

Related Parent Nucleus of
[ 56741-94-7 ]

Pyrimidines

Chemical Structure| 124703-78-2

[ 124703-78-2 ]

6-Ethylpyrimidin-4(3H)-one

Similarity: 0.75

Chemical Structure| 3524-87-6

[ 3524-87-6 ]

6-Methylpyrimidin-4(3H)-one

Similarity: 0.66

Chemical Structure| 59341-68-3

[ 59341-68-3 ]

6-Methyl-2-(pyridin-4-yl)pyrimidin-4(3H)-one

Similarity: 0.64

Chemical Structure| 77994-12-8

[ 77994-12-8 ]

2,5-Diaminopyrimidin-4(3H)-one

Similarity: 0.61

Chemical Structure| 56741-95-8

[ 56741-95-8 ]

2-Amino-5-bromo-4-hydroxy-6-phenylpyrimidine

Similarity: 0.60

; ;